Navigation Links
DuPont Receives ‘Patents for Humanity’ Award for Groundbreaking Research to Improve Nutritional Profile of Staple Crop
Date:4/15/2013

JOHNSTON, Iowa (PRWEB) April 15, 2013

DuPont has been honored by the United States Patent and Trademark Office (USPTO), an agency of the Department of Commerce, for its research efforts to improve nutrition, production and availability of sorghum, a staple crop in Africa. The USPTO Patents for Humanity is an awards competition to recognize patented technologies that address humanitarian needs.

“This award recognizes the importance of collaboration across the public and private sectors to bring real solutions to the people and places that need it most,” said Paul E. Schickler, president, DuPont Pioneer. “Science must be at the heart of solutions to feeding a growing population.”

In Africa, each year up to half a million children become blind from vitamin A deficiencies and nearly 600,000 women die from childbirth-related causes, many from complications that could be reduced through better provision of vitamin A, iron or zinc. Nearly 300 million people in Africa depend on sorghum as a staple crop, but do not have access to another staple that provides the essential nutrients that sorghum lacks.

“I congratulate DuPont for their efforts to improve the nutritional quality of sorghum,” said U.S. Senator and Chair of the Senate Committee on Agriculture, Nutrition, and Forestry Debbie Stabenow (Michigan). “This is a sterling example of how American innovation and modern agricultural technologies help feed a growing world population.”

DuPont established collaborations with a number of organizations, including Africa Harvest Foundation International, the primary coordinating organization for the Africa Biofortified Sorghum (ABS) initiative, to increase the amount and stability of pro-vitamin A, iron and zinc, and improve protein digestibility of sorghum. In the next several years, the ABS initiative is expected to benefit millions of Africans that rely upon sorghum, which traditionally is deficient in key nutrients.

DuPont scientist and lead researcher for the initiative, Marc Albertsen, was presented with the ‘Patents for Humanity’ award at a ceremony held last week in Washington, D.C. The program advances U.S. President Barack Obama’s global development agenda by rewarding companies who bring life-saving technologies to underserved people of the world, while showing how patents are an integral part of tackling the world's challenges. DuPont donated the original technology and has contributed technical and capacity building support to this humanitarian effort.

“From Norman Borlaug to today, Iowan innovations in science and agriculture continue to help feed the world,” added U.S. Congressman Tom Latham (Iowa). “I commend DuPont Pioneer on this tremendous breakthrough that will go to great lengths to improving food security in Africa.”

“Patents and intellectual property rights are fundamental because they encourage continued science-based innovation and allow for investment in future research,” said Schickler.

DuPont Pioneer is the world's leading developer and supplier of advanced plant genetics, providing high-quality seeds to farmers in more than 90 countries. Pioneer provides agronomic support and services to help increase farmer productivity and profitability and strives to develop sustainable agricultural systems for people everywhere. Science with Service Delivering Success™.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders, we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment. For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents filed with the Securities and Exchange Commission by DuPont, particularly its latest annual report on Form 10-K and quarterly report on Form 10-Q, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw materials, research and development of new products, including regulatory approval and market acceptance; seasonality of sales of agricultural products; and severe weather events that cause business interruptions, including plant and power outages, or disruptions in supplier and customer operations. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.

# # #

4/15/13

The DuPont Oval Logo, DuPont™, The miracles of science™ and Science with Service Delivering Success™ are registered trademarks or trademarks of DuPont or its affiliates.

Read the full story at http://www.prweb.com/releases/dupont_pioneer_africa/biofortified_sorghum_abs/prweb10629301.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. DuPont Tells Science Educators They Are Key to Inspiring Students to Pursue Science Excellence
2. Iowa Educator Receives DuPont AgriSCIENCE Award for Teaching Excellence
3. DuPont Collaborates with Agricultural Educators to Reach More Students
4. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
5. DuPont Joins Israel’s Office of the Chief Scientist Global Enterprise R&D Cooperation Framework
6. DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water Use Efficiency and Photosynthesis in Corn
7. DuPont Tate & Lyle Bio Products Announces Winner of Zemea® Innovation Award
8. Genomatica and DuPont Tate & Lyle Bio Products Successfully Produce 1,4-Butanediol (BDO) on Commercial Scale
9. DuPont Pioneer Launches Next Generation T Series Soybeans
10. DuPont, American Farm Bureau Foundation Invests $250,000 in My American Farm Web Education Program
11. DuPont Tate & Lyle Bio Products Announces Innovation Award Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:5/24/2016)... 24, 2016 Ampronix facilitates superior patient care by providing unparalleled technology to ... display is the latest premium product recently added to the range of products distributed ... ... ... Imaging- LCD Medical Display- Ampronix News ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):